Código QR

What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

The fruitful results of tumor immunotherapy establish its indispensable status in the regulation of the tumorous immune context. It seems that the treatment of programmed cell death receptor 1 (PD-1) blockade is one of the most promising approaches for cancer control. The significant efficacy of PD-...

Descrición completa

Gardado en:
Principais autores: Qingyi Wang, Bin Xie, Shuang Liu, Ying Shi, Yongguang Tao, Desheng Xiao, Wenxiang Wang
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Immunology
Assuntos:
immunotherapy
PD-1 inhibitor
tumor microenvironment
cytotoxic T lymphocytes (CTLs)
immunotherapy resistance
combined immunotherapy
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fimmu.2021.773168/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares